A-32 | The Effect of COVID-19 on Outcomes of Non-ST Elevation Myocardial Infarction (NSTEMI): Results from the National Inpatient Sample Database

Moras, Errol; Gandhi, Kruti; Bertasi, Raphael; Bertasi, Tais; Dominguez, Abel Casso

doi:10.1016/j.jscai.2023.100696

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several past studies using the National Inpatient Sample (NIS) database have evaluated different aspects of how the virus influenced the odds and outcomes of AMI patients in 2020 [15][16][17][18]. These studies have offered valuable insights into the intersection of COVID-19 and cardiovascular health, underscoring the increased risks and challenges encountered by individuals affected by both conditions.…”

Section: Introductionmentioning

confidence: 99%

Disparities and Outcomes in the First and Second Year of the Pandemic on Events of Acute Myocardial Infarction in Coronavirus Disease 2019 Patients

Dhaliwal,

Sekhon,

Rajotia

et al. 2024

Medicina

View full text Add to dashboard Cite

Background and Objectives: Coronavirus disease 2019 (COVID-19) caused several cardiovascular complications, including acute myocardial infarction (AMI), in infected patients. This study aims to understand the overall trends of AMI among COVID-19 patients during the first two years of the pandemic and the disparities and outcomes between the first and second years. Materials and Methods: The retrospective analysis was conducted via the 2020 and 2021 National Inpatient Sample (NIS) database for hospitalizations between April 2020 and December 2021 being analyzed for adults with a primary diagnosis of COVID-19 who experienced events of AMI. A comparison of month-to-month events of AMI and mortality of AMI patients with concomitant COVID-19 was made alongside their respective patient characteristics. Results: Out of 2,541,992 COVID-19 hospitalized patients, 3.55% experienced AMI. The highest rate of AMI was in December 2021 (4.35%). No statistical differences in trends of AMI mortality were noted over the 21 months. AMI cases in 2021 had higher odds of undergoing PCI (aOR 1.627, p < 0.01). They experienced higher risks of acute kidney injury (aOR 1.078, p < 0.01), acute ischemic stroke (aOR 1.215, p < 0.01), cardiac arrest (aOR 1.106, p < 0.01), need for mechanical ventilation (aOR 1.133, p < 0.01), and all-cause mortality (aOR 1.032, 95% CI 1.001–1.064, p = 0.043). Conclusions: The incidence of AMI among COVID-19 patients fluctuated over the 21 months of this study, with a peak in December 2021. COVID-19 patients reporting AMI in 2021 experienced higher overall odds of multiple complications, which could relate to the exhaustive burden of the pandemic in 2021 on healthcare, the changing impact of the virus variants, and the hesitancy of infected patients to seek care.

show abstract

Section: Introductionmentioning

confidence: 99%